LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Generated: 2026-08-10
Case ID: NM_002944.2_c.6068A_T_20260810_153608
Framework: ACMG/AMP 2015
Variant classification summary

NM_002944.2:c.6068A>T

ROS1  · NP_002935.2:p.(Tyr2023Phe)  · NM_002944.2
GRCh37: chr6:117638373 T>A  ·  GRCh38: chr6:117317210 T>A
Gene: ROS1 Transcript: NM_002944.2
Final call
VUS
PM2 supporting
All criteria require review: For research and educational purposes only.
Gene
ROS1
Transcript
NM_002944.2
Protein
NP_002935.2:p.(Tyr2023Phe)
gnomAD AF
ClinVar
OncoKB
Unknown Oncogenic Effect
Interpretation summary
Generated evidence synthesis
1
PM2 (Supporting): absent (AF = 0) from gnomAD v2.1 exomes, gnomAD v4.1 exomes, and gnomAD-Canada v1.0 genomes, three independent population datasets.
2
VUS: a single Supporting PM2 satisfies no ACMG/AMP 2015 combination rule for Pathogenic, Likely Pathogenic, Benign, or Likely Benign.
Final determination: Under the generic ACMG/AMP 2015 fallback combination rules (no ROS1 VCEP/CSPEC exists; final_classification_framework found=false), only PM2 at Supporting strength is met; no Pathogenic, Likely Pathogenic, Benign, or Likely Benign combination is satisfied, so the variant resolves to Uncertain Significance (VUS).
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
Criterion Status Rationale Evidence used
PVS1 N/A Not applicable: PVS1 applies only to null variants, and this missense substitution (p.Tyr2023Phe) triggers no null-variant mechanism.
pvs1_generic_framework generic_acmg_combination_rules
PS1 Not assessed Not assessed: no ClinVar record or literature reports exist, so no same-amino-acid pathogenic comparator (p.Tyr2023Phe) was available.
clinvar pm5_candidates
PS2 Not assessed Not assessed: no proband phenotype, family history, or parental genotyping data were available to evaluate a de novo origin.
clinvar generic_acmg_combination_rules
PS3 Not assessed Not assessed: no functional studies exist for this variant; OncoKB reports unknown oncogenic effect.
oncokb spliceai generic_acmg_combination_rules
PS4 Not assessed Not assessed: no case-control or cohort allele-frequency comparison exists for this variant.
gnomad_v2 gnomad_v4 gnomad_canada generic_acmg_combination_rules
PM1 Not met Not met: no statistically significant hotspot at ROS1 Y2023, and no curated ROS1 domain map supports this position. Flagged for human review: no named curated ROS1 domain/hotspot map was available.
PM2 Met Met (Supporting): absent (AF = 0) from gnomAD v2.1, gnomAD v4.1, and gnomAD-Canada v1.0, three independent population datasets. Per-position coverage at this site could not be independently verified.
gnomad_v2 gnomad_v4 gnomad_canada generic_acmg_combination_rules
PM3 N/A Not applicable: PM3 applies only to recessive disorders, and no recessive germline mechanism is established for ROS1.
generic_acmg_combination_rules clinvar pvs1_gene_context
PM4 N/A Not applicable: this missense substitution produces no protein length change, which PM4 requires.
pvs1_generic_framework generic_acmg_combination_rules
PM5 Not assessed Not assessed: no pathogenic variant at the same residue (p.Tyr2023) was identified for comparison.
pm5_candidates clinvar
PM6 Not assessed Not assessed: no de novo occurrence or parental testing results were reported for this variant.
clinvar generic_acmg_combination_rules
PP1 Not assessed Not assessed: no pedigree or family segregation data exist for this variant.
clinvar generic_acmg_combination_rules
PP2 Not assessed Not assessed: no ROS1 missense-constraint data (e.g., gnomAD Z-score) were available.
pvs1_gene_context oncokb
PP3 Not met Not met: SpliceAI max delta 0.01 predicts no splice impact, and REVEL 0.52 is uninformative (below 0.773, above 0.016).
spliceai revel bayesdel generic_acmg_combination_rules
PP4 Not assessed Not assessed: no carrier phenotype or clinical case description was available for this variant.
oncokb generic_acmg_combination_rules
PP5 Not met Not met: this variant has no ClinVar record, so no expert-panel pathogenic classification exists to support PP5.
clinvar generic_acmg_combination_rules
BA1 Not met Not met: allele frequency is 0 in all queried population databases, far below the >5% BA1 threshold.
gnomad_v2 gnomad_v4 gnomad_canada generic_acmg_combination_rules
BS1 Not met Not met: absent (AF = 0) from population databases, so the frequency cannot exceed any disease-consistent threshold.
gnomad_v2 gnomad_v4 gnomad_canada generic_acmg_combination_rules
BS2 Not met Not met: no healthy-adult carriers of this variant were observed in any population cohort.
gnomad_v2 gnomad_v4 gnomad_canada generic_acmg_combination_rules
BS3 Not assessed Not assessed: no functional studies demonstrating a benign effect on protein function or splicing exist.
oncokb spliceai clinvar generic_acmg_combination_rules
BS4 Not assessed Not assessed: no family segregation testing data exist for this variant.
clinvar generic_acmg_combination_rules
BP1 Not met Not met: ROS1 disease is not limited to truncating variants; non-truncating alterations are disease-relevant.
pvs1_gene_context oncokb
BP2 Not assessed Not assessed: no allele-phase (trans/cis) observation with a pathogenic variant exists for this variant. Flagged for human review: no external family or allele-phase data were available.
generic_acmg_combination_rules clinvar pvs1_gene_context
BP3 N/A Not applicable: BP3 applies to in-frame indels in repeat regions, not missense substitutions.
pvs1_generic_framework generic_acmg_combination_rules
BP4 Not met Not met: only SpliceAI (max delta 0.01) supports no impact, and REVEL 0.52 is uninformative, so the multiple-lines requirement fails.
spliceai revel bayesdel generic_acmg_combination_rules
BP5 Not assessed Not assessed: no proband-level data exist to evaluate an alternative molecular basis for disease.
generic_acmg_combination_rules
BP6 Not met Not met: this variant has no ClinVar record, so no expert-panel benign classification exists to support BP6.
clinvar generic_acmg_combination_rules
BP7 N/A Not applicable: BP7 applies only to synonymous variants, and this is a missense substitution.
generic_acmg_combination_rules
Disclaimer: The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.